GSK’s Zejula reduces risk of progression and death in mesothelioma study
Data from the NERO study was presented at the American Association of Cancer Research (AACR) Annual Meeting 2025.
01 May 2025
01 May 2025
Data from the NERO study was presented at the American Association of Cancer Research (AACR) Annual Meeting 2025.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.